Are progesterone transdermal patches commercially available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Are Progesterone Patches Available?

Progesterone-only transdermal patches are NOT commercially available for clinical use, but combined estradiol-progestin patches ARE available and widely used in hormone therapy. 1, 2, 1

What IS Available

Combined Estradiol-Progestin Patches

The following transdermal patch combinations are commercially available 1:

  • Estradiol-levonorgestrel patches (both sequential and continuous formulations)
  • Estradiol-norethindrone acetate patches

These combined patches deliver both estrogen and a progestogen (not progesterone itself, but synthetic progestins) through the skin 2.

Sequential regimens: Estradiol alone for 2 weeks, followed by combined estradiol + progestin (e.g., 10 μg levonorgestrel) for 2 weeks 2

Continuous regimens: Both hormones delivered continuously (e.g., 50 μg estradiol + 7 μg levonorgestrel daily) 2

What Is NOT Available

Pure progesterone transdermal patches for systemic hormone therapy do not exist as approved commercial products. 3 states explicitly that "there is insufficient evidence from scientific studies to substantiate the transdermal application of progesterone" and warns that transdermal progesterone preparations "should not be used to oppose the effects of oestrogen on the endometrium."

Clinical Alternatives When Patches Are Needed

If you need transdermal estrogen but combined patches aren't suitable, the recommended approach is 2:

  1. Transdermal estradiol patches (50-100 μg daily) administered continuously
  2. PLUS oral or vaginal micronized progesterone added cyclically for 12-14 days every 28 days:
    • Oral/vaginal micronized progesterone: 200 mg daily
    • OR oral medroxyprogesterone acetate: 10 mg daily
    • OR oral dydrogesterone: 10 mg daily

Micronized progesterone is the preferred progestin due to lower cardiovascular and thromboembolic risk 2.

Important Caveats

  • The FDA-approved progesterone formulations are oral capsules only (100 mg, 200 mg) 4
  • Research on experimental progesterone patches exists 5, 6, 7, 8, but these are investigational only
  • Transdermal progesterone creams available through compounding pharmacies lack evidence for endometrial protection and should be avoided 3

Bottom line: Use commercially available combined estradiol-progestin patches, or combine transdermal estradiol with oral/vaginal progesterone—never rely on progesterone-only transdermal products for endometrial protection.

References

1
Guideline

american association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

5
Research

Design and in vitro/in vivo evaluation of a compound estradiol-progesterone patch for the treatment of menopausal syndrome.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2026

Related Questions

What is the best transdermal patch for managing menopausal hot flashes in a woman without contraindications, and is cyclic progesterone required if she has an intact uterus?
In a 47-year-old woman with early menopause, osteopenia, and a stable BIRADS 3 breast lesion, who is using a 0.1 mg/day transdermal estradiol patch and nightly 300 mg progesterone, has a low serum estradiol (<23 pg/mL) and symptoms of irritability, brain fog, and occasional hot flashes, should her hormone replacement therapy be adjusted?
What are the consequences of a 55‑year‑old woman with an intact uterus taking two daily 100 mg Prometrium (micronized progesterone) capsules instead of the prescribed one while on Oestrogel (estradiol) transdermal hormone replacement therapy?
Should I remove a contraceptive transdermal patch if there is bleeding at the application site?
What is the differential diagnosis, appropriate work‑up, and management for a 22‑year‑old woman with markedly low progesterone (<0.5 ng/mL) and low estradiol (<30 pg/mL)?
Are there any contraindications to initiating selective serotonin reuptake inhibitor (SSRI) therapy in a 22-year-old autistic male with depression and anxiety?
What travel health advice should be given to a healthy adult traveling to Zambia?
What is the recommended starting dose of Lexapro (escitalopram) for an adult?
What is the maximum dosage of omega‑3 fatty acids (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) for treating uncontrolled hypertriglyceridemia?
Which autoimmune laboratory tests should be ordered for a 39-year-old male with no past medical history who has alternating eye redness?
What is the drug interaction between baclofen and divalproex sodium?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.